Financials
Financial year 2025
DR. S. UYTDENHOUWEN from Gent, company number BE0891740992, closed financial year 2025 with a result of € 4,506 after tax. For that financial year DR. S. UYTDENHOUWEN recorded a gross margin of € 10,092 and equity of € 44,617. Compared with financial year 2024, the result moved from € 1,032 to € 4,506. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 22, 2026.
€ 44,617
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 4,506
▲ € 3,474 vs 2024
Profit after tax over the fiscal year.
€ 37,324
▲ 37% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 860 paid out
19 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 1,193
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 917
▼ 43% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 1,800
▲ € 1,607 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 7,208 | € 7,415 | € 5,837 | € 10,092 | ▲ 73% |
| Profit after taxes | € 3,073 | € 2,837 | € 1,032 | € 4,506 | ▲ € 3,474 |
| Equity | € 37,103 | € 39,940 | € 40,972 | € 44,617 | ▲ 9% |
| Total debts | € 3,132 | € 2,434 | € 2,876 | € 4,010 | ▲ 39% |
| Cash | € 37,675 | € 37,624 | € 27,155 | € 37,324 | ▲ 37% |
| Retained profit | € 24,703 | € 27,540 | € 28,572 | € 32,217 | ▲ 13% |
| Dividend | € 0 | € 0 | € 0 | € 860 | |
| Balance sheet total | € 40,235 | € 42,374 | € 43,848 | € 48,628 | ▲ 11% |
Key figures of DR. S. UYTDENHOUWEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
What happened to DR. S. UYTDENHOUWEN?
What happened at DR. S. UYTDENHOUWEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 4,506 (▲ € 3,474 vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- Sarah Uytdenhouwen became a director. NBB
In short
From € 3,073 profit in 2022 to € 4,506 profit in 2025.
Paid € 2,959 in corporate taxes since 2022.
Best year ever: 2025, with € 4,506 profit.
Paid out € 860 in dividends to the owners in total.
Management
Behind DR. S. UYTDENHOUWEN is Sarah Uytdenhouwen.
Directors
According to the 2025 annual accounts
Sarah Uytdenhouwen
Director
since 2007
Establishments
Establishment units
Physical locations of this company
Augustijn Moreelsstraat 30
9041 Gent
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- UYTDENHOUWEN Sarah(oprichter) 100%
Details
- Company number
- 0891.740.992
- VAT number
- BE 0891.740.992
- Registered office
- Augustijn Moreelsstraat 30, 9041 Gent
- Names & denominations
- DR. S. UYTDENHOUWEN
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 August 2007
- Peppol
- Active · Active since 21 Oct 2026
- Activities · NACE
Activiteiten van huisartspraktijken
Activiteiten van medisch specialisten